Tick salivary cystatin sialostatin L2 suppresses IFN responses in mouse dendritic cells

Parasite Immunology

Volumn 37, Issue 2, 2015, Pages 70-78

  Lieskovská, Jaroslava ^a,b   Palenikova J ^a,b   Sirmarova J ^c   Elsterova J ^a,b,c   Kotsyfakis, M ^b   Campos Chagas, A ^d   Calvo, E ^d   Ruzek D ^a,b,c   Kopecky J ^a,b  

^a UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^b INSTITUTE OF PARASITOLOGY   (Czech Republic)

^c VETERINARY RESEARCH INSTITUTE   (Czech Republic)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cystatin; Dendritic cell; Interferon; Tick

Indexed keywords

BETA INTERFERON; BETA INTERFERON RECEPTOR; CYSTATIN S; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 7; JANUS KINASE; LIPOPOLYSACCHARIDE; SIALOSTATIN L2; STAT PROTEIN; UNCLASSIFIED DRUG; CYSTATIN; CYTOKINE RECEPTOR; INTERFERON RECEPTOR; IP10-MIG RECEPTOR; IRF7 PROTEIN, MOUSE; SIALOSTATIN L, IXODES SCAPULARIS;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; GENE EXPRESSION; GENE INDUCTION; INTERNALIZATION; IXODES SCAPULARIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPLEEN; TICK BORNE ENCEPHALITIS VIRUS; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; BORRELIA BURGDORFERI; C57BL MOUSE; DENDRITIC CELL; IMMUNOLOGY; IXODES; METABOLISM; MICROBIOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

IXODES SCAPULARIS; IXODIDA; IXODIDAE; TICK-BORNE ENCEPHALITIS VIRUS;

ANIMALS; BORRELIA BURGDORFERI; CYSTATINS; DENDRITIC CELLS; FEMALE; INTERFERON REGULATORY FACTOR-7; INTERFERON-BETA; IXODES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; RECEPTORS, CYTOKINE; RECEPTORS, INTERFERON; SALIVARY CYSTATINS;

EID: 84921404085     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12162     Document Type: Article

References (31)

1. Francischetti IM, Sa-Nunes A, Mans BJ, Santos IM & Ribeiro JM. The role of saliva in tick feeding. Front Biosci 2009; 14: 2051-2088.
2. Wikel S. Ticks and tick-borne pathogens at the cutaneous interface: host defenses, tick countermeasures, and a suitable environment for pathogen establishment. Front Microbiol 2013; 4: 337.
3. Kotsyfakis M, Karim S, Andersen JF, Mather TN & Ribeiro JM. Selective cysteine protease inhibition contributes to blood-feeding success of the tick Ixodes scapularis. J Biol Chem 2007; 282: 29256-29263.
4. Kotsyfakis M, Sa-Nunes A, Francischetti IM, Mather TN, Andersen JF & Ribeiro JM. Antiinflammatory and immunosuppressive activity of sialostatin L, a salivary cystatin from the tick Ixodes scapularis. J Biol Chem 2006; 281: 26298-26307.
5. Kotsyfakis M, Anderson JM, Andersen JF, Calvo E, Francischetti IM, Mather TN, et al. Immunity against a "silent" salivary antigen of the Lyme vector Ixodes scapularis impairs its ability to feed. J Immunol 2008; 181: 5209-5212.
6. Kotsyfakis M, Horka H, Salat J & Andersen JF. The crystal structures of two salivary cystatins from the tick Ixodes scapularis and the effect of these inhibitors on the establishment of Borrelia burgdorferi infection in a murine model. Mol Microbiol 2010; 77: 456-470.
7. Chen G, Wang X, Severo MS, Sakhon OS, Sohail M, Brown LJ, et al. The Tick salivary protein sialostatin L2 inhibits caspase-1-mediated inflammation during Anaplasma phagocytophilum infection. Infect Immun 2014; 82: 2553-2564.
8. Horka H, Staudt V, Klein M, Taube C, Reuter S, Dehzad N, et al. The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma. J Immunol 2012; 188: 2669-2676.
9. Sa-Nunes A, Bafica A, Antonelli LR, Choi EY, Francischetti IM, Andersen JF, et al. The immunomodulatory action of sialostatin L on dendritic cells reveals its potential to interfere with autoimmunity. J Immunol 2009; 182: 7422-7429.
10. Kelsall BL, Biron CA, Sharma O & Kaye PM. Dendritic cells at the host-pathogen interface. Nat Immunol 2002; 3: 699-702.
11. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005; 5: 375-386.
12. Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, Bates EE, et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005; 201: 1435-1446.
13. Lieskovska J & Kopecky J. Tick saliva suppresses IFN signalling in dendritic cells upon Borrelia afzelii infection. Parasite Immunol 2012; 34: 32-39.
14. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693-1702.
15. Livak KJ & Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
16. De Madrid AT & Porterfield JS. A simple micro-culture method for the study of group B arboviruses. Bull World Health Organ 1969; 40: 113-121.
17. Coccia EM, Uze G & Pellegrini S. Negative regulation of type I interferon signaling: facts and mechanisms. Cell Mol Biol 2006; 52: 77-87.
18. Huangfu WC & Fuchs SY. Ubiquitination-dependent regulation of signaling receptors in cancer. Genes Cancer 2010; 1: 725-734.
19. Coccia EM, Severa M, Giacomini E, Monneron D, Remoli ME, Julkunen I, et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004; 34: 796-805.
20. Ohmori Y & Hamilton TA. Requirement for STAT1 in LPS-induced gene expression in macrophages. J Leukoc Biol 2001; 69: 598-604.
21. Severa M, Remoli ME, Giacomini E, Ragimbeau J, Lande R, Uze G, et al. Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression. J Leukoc Biol 2006; 79: 1286-1294.
22. Fitzgerald-Bocarsly P & Feng D. The role of type I interferon production by dendritic cells in host defense. Biochimie 2007; 89: 843-855.
23. Kaisho T & Akira S. Regulation of dendritic cell function through Toll-like receptors. Curr Mol Med 2003; 3: 373-385.
24. Hendry L & John S. Regulation of STAT signalling by proteolytic processing. Eur J Biochem 2004; 271: 4613-4620.
25. Montoya M, Schiavoni G, Mattei F, Gresser I, Belardelli F, Borrow P, et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 2002; 99: 3263-3271.
26. Klotz C, Ziegler T, Danilowicz-Luebert E & Hartmann S. Cystatins of parasitic organisms. Adv Exp Med Biol 2011; 712: 208-221.
27. Rivera-Rivera L, Perez-Laspiur J, Colon K & Melendez LM. Inhibition of interferon response by cystatin B: implication in HIV replication of macrophage reservoirs. J Neurovirol 2012; 18: 20-29.
28. Luciano-Montalvo C & Melendez LM. Cystatin B associates with signal transducer and activator of transcription 1 in monocyte-derived and placental macrophages. Placenta 2009; 30: 464-467.
29. Sin WX, Li P, Yeong JP & Chin KC. Activation and regulation of interferon-beta in immune responses. Immunol Res 2012; 53: 25-40.
30. Honda K & Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006; 6: 644-658.
31. Daffis S, Samuel MA, Suthar MS, Keller BC, Gale M Jr & Diamond MS. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol 2008; 82: 8465-8475.